Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Dec 2025 for Genscript Biotech Corporation.
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Grossman Ross: trading record in brief
Grossman Ross discloses dealings in Genscript Biotech Corporation to HKEX. Over a trading history stretching from 19 November 2024 to 15 December 2025, the count stands at 2 filings.
Every open-market trade on record is a purchase: 2 purchases, and no sale. No amount is published for 2 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2025: 2 purchases and no sales on the market.
The record was last updated on 18 December 2025 with an open-market purchase in Genscript Biotech Corporation. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Companies and markets linked to Grossman Ross
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
18,157 sharesShareXHKGHKEX:DA20251218E00303
Canonical exit: 15 Mar 2026 (T+90)
21,905 sharesShareXHKGHKEX:DA20250103E00522
Canonical exit: 17 Feb 2025 (T+90)
2 of 2 declarations
